Growth Milestones
LENSAR increase global market share from 13 to 16%
LENSAR achieved significant growth milestones during 2020, including an increase in global market share from 13 to 16%, a 10% increase in customer installed base and a 15% increase in procedure volume in their two largest markets, according to the company. “We maintained our leading laser system utilisation position with an average of 430 procedures performed per laser vs. 232 with competitive systems. These successes are a testament to our dedication to bringing ophthalmic surgeons the most advanced and beneficial laser system available today,” said Nick Curtis, Chief Executive Officer of LENSAR. “I am also pleased to report that we remain on track to file the 510K application in the first quarter of 2022 and launch ALLY later that year,” said Mr Curtis.
www.lensar.com
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
How Many Surgeries Equal Surgical Proficiency?
Internet, labs, simulators, and assisting surgery all contribute.